Skip to main content

Table 7 Cost-effectiveness for diagnosing and treating diarrhoea per 100 eligible children from de societal perspective in 2014 (US$)

From: Cost-effectiveness analysis of the national implementation of integrated community case management and community-based health planning and services in Ghana for the treatment of malaria, diarrhoea and pneumonia

Variables

Volta Regionb

Northern Region

iCCM

CHPS

iCCM

CHPS

Number of eligible children for treatment

100

100

 

100

Number treated with ORS (or referred)a

8

11

 

7

Number treated with ORS and zinc (or referred)

11

7

 

4

Number treated according to protocol (ORS or referred)

59

57

 

62

Number treated according to protocol (ORS and zinc)

54

43

 

59

Costs per 100 children (ORS)

US$6.84

US$83.20

 

US$38.88

Cost per 100 children (ORS and zinc)

US$9.78

US$47.54

 

US$19.44

Cost per child treated according to protocol (ORS or referred)

US$0.12

US$1.45

 

US$0.62

Cost per child treated according to protocol (ORS and zinc)

US$0.18

US$1.12

 

US$0.33

Incremental costs per 100 children (ORS or referred)

US$76.35

   

Incremental effect per 100 children (ORS or referred)

2

   

Incremental cost-effectiveness ratio (ORS or referred)

iCCM is dominant

Incremental costs per 100 children (ORS or referred)

US$37.76

   

Incremental effect per 100 children (ORS or zinc)

11

   

Incremental cost-effectiveness ratio (ORS and zinc)

iCCM is dominant

  1. a Source Additional file 2
  2. bAppropriate treatment for diarrhoea under the iCCM strategy in the Volta Region includes those treated with ORS and zinc or referred for further management. The cost per treatment of those referred is included to allow comparison with CHPS